Cellebrite DI Stock

Detail	Data
Volume (24h):	1,485,415 shares
P/E Ratio:	/
Forward P/E:	40.65
EPS:	-0.92 USD
Forward EPS:	0.4 USD
Number of Shares:	239,470,000 shares
Market Capitalization:	3,893,782,272.00 USD

The interactive chart displays the price movement of Cellebrite DI shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

Dividend	Value
Dividend Amount	According to our data, the company Cellebrite DI does not currently pay dividends.
Annual Yield %:	-
Ex-dividend Date:	-
5-Year Avg Yield %:	-
Payout Ratio:	-
Last Dividend Value:	-
Last Dividend Date:	-

Analyst Forecast

Most analysts have issued a strong_buy recommendation for Cellebrite DI stock. The current number of analysts covering this company is 7. The highest target price is 28 USD, while the lowest target price is 20 USD. The median target valuation set by analysts is 24 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Cellebrite DI.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Cellebrite DI stock is: strong_buy
Number of Analysts:	7
Highest Target Price:	28 USD
Lowest Target Price:	20 USD
Median Target Price:	24 USD

Fundamental Indicators

Indicator	Data
Total Revenue:	419,169,984.00 USD
Net Income:	-194,235,008.00 USD
Price-to-Book (P/B):	10.61
PEG Ratio:	/
Exchange:	NasdaqGS
Industry:	Software - Infrastructure
Sector:	Technology
Number of Employees:	1167
Country:	Israel

Where to Buy Cellebrite DI Stock?

You can purchase Cellebrite DI stock on the NasdaqGS under the ticker symbol: CLBT. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Cellebrite DI Stock

Indicator	Value
Company Revenue:	419,169,984.00 USD
EBITDA:	70,485,000.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	-0.92 USD
Book Value Per Share:	1.53 USD
Total Cash:	409,486,016.00 USD
Total Cash per Share:	1.73 USD
Total Debt:	10,603,000.00 USD
Debt to Equity Ratio:	0.03
Quick Ratio	1.71
Current Ratio	1.82
Free Cash Flow	112,159,376.00 USD
Operating Cash Flow	143,008,000.00 USD
Gross Margins	84.06 %
EBITDA Margins	16.82 %
Operating Margins	11.41 %
Profit Margins	-46.34 %
Return on Assets	6.0 %
Return on Equity	-115.3 %
Earnings Growth (1 year)	-
Revenue Growth (1 year)	20.1 %
Quarterly Earnings Year-over-Year Growth	-
Market Capitalization	3,893,782,272.00 USD
Enterprise Value	3,458,747,648.00 USD
EV/Revenue	8.251
EV/EBITDA	49.071
Float Shares	106,414,614 shares
Shares Outstanding	239,470,000 shares
Held Percent Insiders	0.46 %
Held Percent Institutions	47.76 %
Shares Short	1,065,060
Shares Short Prior Month	988,163
Date Short Interest	2025-05-30
Short Percentage of Total Shares	0.44 %
Short Ratio	0.75
Beta	1.32
Short Percentage of Float	0.92 %
Implied Shares Outstanding	245,303,008

Frequently Asked Questions (FAQ)

1️⃣ Does Cellebrite DI pay dividends?

According to our data, the company Cellebrite DI does not pay dividends yet, even in 2025.

2️⃣ Where to buy Cellebrite DI shares?

Cellebrite DI shares are traded on the NasdaqGS stock exchange under the ticker: CLBT. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Cellebrite DI shares?

According to our data, the recommendation for Cellebrite DI shares is from a total of 7 analysts. The average target price prediction is 24 USD per share.

4️⃣ What is the total number of shares and the value of Cellebrite DI on the stock exchange?

The total number of Cellebrite DI shares on the exchange is 239,470,000.00 shares, which at the current market capitalization gives the company a total valuation of 3,893,782,272.00 USD.